BioCentury | Jul 23, 2012
Clinical News

14-type high-risk HPV test regulatory update

...Hologic said the Netherlands Society for Pathology approved the use of the company's Cervista HPV HR test for detecting...
...determine the need for referral to colposcopy. Hologic Inc. (NASDAQ:HOLX), Bedford, Mass. Product: 14-type high-risk HPV test , Cervista HPV HR test...
BioCentury | Jan 2, 2012
Company News

Hologic sales and marketing update

...Cervista high throughput automation (HTA) system in the U.S. this month for use with its Cervista HPV HR test...
BioCentury | Jul 19, 2010
Clinical News

14-type high-risk HPV test: Final post-marketing study data

...for the identification of confirmed cervical intraepithelial neoplasia grade 2+ (CIN2+) was statistically equivalent for Cervista HPV HR test...
...has CE Mark approval in the EU. Hologic Inc. (NASDAQ:HOLX), Bedford, Mass. Product: 14-type high-risk HPV test , Cervista HPV HR test...
BioCentury | Apr 5, 2010
Clinical News

14-type high-risk HPV test: Interim post-marketing study data

...5,043 patients in the Chinese post-marketing SHENCCAST II trial in >10,000 women showed that Hologic's Cervista HPV HR test...
...has CE Mark approval in the EU. Hologic Inc. (NASDAQ:HOLX), Bedford, Mass. Product: 14-type high-risk HPV test , Cervista HPV HR test...
BioCentury | Oct 26, 2009
Clinical News

16/18 genotyping HPV test regulatory update

...negative pap smear. Hologic markets its Cervista HPV 16/18 test as an adjunct with the Cervista HPV HR test...
BioCentury | Mar 23, 2009
Clinical News

14-type high-risk HPV test regulatory update

...FDA approved a PMA from Hologic for its Cervista HPV HR test to detect 14 high-risk types of human...
...in 2008 (see BioCentury, June 16, 2008). Hologic Inc. (NASDAQ:HOLX), Bedford, Mass. Product: 14-type high-risk HPV test , Cervista HPV HR test...
BioCentury | Mar 23, 2009
Clinical News

16/18 genotyping HPV test regulatory update

...a PMA from Hologic for its Cervista HPV 16/18 test as an adjunct with the Cervista HPV HR test...
BioCentury | Nov 24, 2008
Clinical News

14-type high-risk HPV test diagnostic data

...Technologies Inc. earlier this year (see BioCentury, June 16). Hologic Inc. (NASDAQ:HOLX), Bedford, Mass. Product: 14-type high-risk HPV test...
BioCentury | Jun 16, 2008
Company News

Hologic, Third Wave deal

...HPV tests, for which it hopes to receive FDA approval in 1H09. Cervista HR, a 14-type high-risk HPV test...
BioCentury | Jun 10, 2008
Top Story

Hologic to acquire Third Wave

...HPV tests, for which it hopes to receive FDA approval in 1H09. Cervista HR, a 14-type high-risk HPV test...
Items per page:
1 - 10 of 18